This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sunshine Lake Pharma Co., Ltd.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations of Hongxing Han in Borosilicate Glass Technology
Introduction
Hongxing Han is a notable inventor based in Dongguan, China. He has made significant contributions to the field of materials science, particularly in the development of borosilicate glass. His innovative work focuses on enhancing the chemical resistance of glass, which is crucial for various applications, especially in the pharmaceutical industry.
Latest Patents
One of Hongxing Han's key patents is for a borosilicate glass with high chemical resistance. This invention discloses a borosilicate glass that contains 0.25-4.0 wt % of Y2O3 based on the oxide. The glass exhibits high chemical stability and a suitable linear thermal expansion coefficient, making it ideal for use in pharmaceutical packaging materials. This patent highlights his expertise in creating materials that meet stringent industry requirements.
Career Highlights
Hongxing Han is currently associated with Sunshine Lake Pharma Co., Ltd. His role in the company allows him to apply his innovative ideas in practical settings, contributing to advancements in pharmaceutical packaging. His work is recognized for its impact on improving the safety and efficacy of drug delivery systems.
Collaborations
Hongxing Han has collaborated with notable colleagues such as Weiqiang Hong and Zhengshang Zhou. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of materials science.
Conclusion
Hongxing Han's contributions to the development of borosilicate glass with high chemical resistance exemplify his commitment to innovation in materials science. His work not only advances technology but also enhances the safety and effectiveness of pharmaceutical products.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile